Why the study?
Aortic regurgitation is associated with significant morbidity and mortality, while transcatheter therapies remain in infancy and further data are needed.
Answers are grounded in this paper and cite their sources.
This review provides a comprehensive overview of aortic regurgitation, highlighting the role of non-invasive imaging in diagnosis and the emerging potential of transcatheter therapies alongside traditional surgical replacement.
Aortic regurgitation (AR) is a common clinical disease associated with significant morbidity and mortality. Investigations based largely on non-invasive imaging are pivotal in discerning the severity of disease and its impact on the heart. Advances in technology have contributed to improved risk stratification and to our understanding of the pathophysiology of AR. Surgical aortic valve replacement is the predominant treatment. However, its use is limited to patients with an acceptable surgical risk profile. Transcatheter aortic valve implantation is an alternative treatment. However, this therapy remains in its infancy, and further data and experience are required. This review article on AR describes its prevalence, mechanisms, diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Baumbach et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: